EUROTOX 2026

Toxys at Eurotox

EUROTOX 2026

EUROTOX 2026 will be held at the Austria Center Vienna (ACV) where we will celebrate the 60th birthday of this congress series. The congress serves to increase the exchange of scientific information between toxicologists in academia, regulatory, and industry across Europe, as well as from other geographical regions of the world.

The scientific programme addresses trend topics such as how to reduce reliance on animal models or the need for relevant NAMs in DART.

eurotox logo

Curious about how Toxys NAMs can help reduce reliance on animal models?

Join our Industry Hosted Session

Register Now

Mechanistic Toxicology Forward: New ToxTracker Test Guideline, Industry Use Cases & Emerging NAMs for DART and Mitochondrial Toxicity

Date: Tuesday, 15 September 2026

Time: 12:15 – 13:15

Location: Hall F1 (Level 0)

Chair: Paula van Rossum, Chief Business Officer, Toxys

New approach methodologies (NAMs) are reshaping modern toxicology by enabling human-relevant, mechanism-based approaches for safety assessment while supporting the reduction of animal use.

In this sponsored session, we’ll present recent advances in the development, validation, and implementation of innovative NAMs across genetic, mechanistic, and developmental toxicology. We will discuss the details and practical implications of the recently published OECD TG 446A for ToxTracker and its increasing adoption in industrial and regulatory testing strategies.

The session will also introduce two emerging in vitro assays designed to address complex toxicity endpoints: a novel mitochondrial toxicity assay based on the ToxProfiler platform and an innovative developmental toxicity assay for identifying skeletal developmental effects.

Together, these technologies demonstrate how mechanism-based NAMs can improve the predictive power and human relevance of safety assessment.

Join us to gain practical insights into NAMs applications in modern safety assessment and the evolving path toward broader regulatory acceptance.

Session Programme – 12:15-13:15
  • ToxTracker OECD TG 446A and Strategic Positioning in (regulatory) Safety Testing – Giel Hendriks, CEO at Toxys
  • Advancing Mitochondrial Toxicity Detection in a Screening Platform – Tamara Meijer, Study Director at Toxys
  • NAMs for Detecting Skeletal Malformations as part of DART Assessment – Paula van Rossum, CBO at Toxys
  • Integrating ToxTracker into Innovative Safety Assessments: Strategic Applications – Myrthe van den Dungen, Senior Toxicologist at DSM-Firmenich
Register Now
Tamara Meijer

Don’t miss our poster presentations

P30-31 “Advancing mitochondrial toxicity detection using a human reporter-based imaging platform.

Session: Risk Prediction and Assessment /Risk assessment using New Approach Methodologies

Date: Tuesday, 15 September 2026, 9:30 – 16:30

Abstract ID: 1328

Tamara Meijer, Director at Toxys

Paula van Rossum
P28-33 “Introduction of human-induced pluripotent stem cell (hiPSCs)-derived osteoblasts in the ReproTracker assay for in vitro assessment of skeletal malformations

Session: Reproductive and Developmental Toxicology

Date: Tuesday, 15 September 2026, 9:30 – 16:30

Abstract ID: 1332

Paula van Rossum, CBO at Toxys

Meet Us at EUROTOX Exhibition Booth #56

Stop by our booth for insightful conversations on integrating validated NAMs across genetic, developmental, and investigative toxicology. We’re here to help.

Schedule a Meeting

Poster Presentations by Others with Toxys Assays

P14-41 – Mechanistic Insight Into Henna’s Dye: NAMs Clarify Lawsone’s Genotoxicity Profile  (#1578) – 14 Sept 9.30

P18-66 – blu bar® kit aerosol showed substantially lower biological activity in CORESTA and ToxTracker® in vitro assays compared to cigarette smoke – 14 Sept 9.30

P27-03 – Mechanistically informed in vitro genotoxicity model for complex molecules: NAMs to prevent unnecessary in vivo follow-up tests in Regulatory Field – 15 Sept 9.30

S12-03 – Assessing in vitroHuman-Relevant Teratogenicity Assays in the Context of TPDs – 15 Sept 11.00

P18-116 – Assessment of Developmental Toxicity of Butyl Methoxydibenzoylmethane (BMDBM) for cosmetic use Using New Approach Methodologies (NAMs) – 14 Sept 9.30

For an overview on our assays portfolio, you can visit our services and products page. We are happy to tell you more about them at the event.


Event location: Vienna
Event website: Event website
Share